AU2001241816A1 - Methods for promoting production of myelin by schwann cells - Google Patents

Methods for promoting production of myelin by schwann cells

Info

Publication number
AU2001241816A1
AU2001241816A1 AU2001241816A AU4181601A AU2001241816A1 AU 2001241816 A1 AU2001241816 A1 AU 2001241816A1 AU 2001241816 A AU2001241816 A AU 2001241816A AU 4181601 A AU4181601 A AU 4181601A AU 2001241816 A1 AU2001241816 A1 AU 2001241816A1
Authority
AU
Australia
Prior art keywords
myelin
methods
schwann cells
promoting production
promoting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001241816A
Inventor
Emma E Moore
Julia E. Novak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zymogenetics Inc
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of AU2001241816A1 publication Critical patent/AU2001241816A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2001241816A 2000-02-29 2001-02-27 Methods for promoting production of myelin by schwann cells Abandoned AU2001241816A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US51522300A 2000-02-29 2000-02-29
US09515223 2000-02-29
PCT/US2001/006294 WO2001064240A2 (en) 2000-02-29 2001-02-27 Methods for promoting production of myelin by schwann cells

Publications (1)

Publication Number Publication Date
AU2001241816A1 true AU2001241816A1 (en) 2001-09-12

Family

ID=24050447

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001241816A Abandoned AU2001241816A1 (en) 2000-02-29 2001-02-27 Methods for promoting production of myelin by schwann cells

Country Status (5)

Country Link
EP (1) EP1259253A2 (en)
JP (1) JP2003525251A (en)
AU (1) AU2001241816A1 (en)
CA (1) CA2401716A1 (en)
WO (1) WO2001064240A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040234500A1 (en) * 2001-03-26 2004-11-25 Moore Emma E. Method for inducing proliferation of retinal stem cells
CA2669109A1 (en) * 2006-11-08 2008-06-19 Zymogenetics, Inc. Il-17b for use in wound healing
CA2961027A1 (en) 2014-09-12 2016-03-17 The Administrators Of The Tulane Educational Fund Neural microphysiological systems and methods of using the same
EP3452598A4 (en) 2016-05-06 2020-04-29 Exicure, Inc. Liposomal spherical nucleic acid (sna) constructs presenting antisense oligonucleotides (aso) for specific knockdown of interleukin 17 receptor mrna
US11696954B2 (en) 2017-04-28 2023-07-11 Exicure Operating Company Synthesis of spherical nucleic acids using lipophilic moieties

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000073452A2 (en) * 1999-06-02 2000-12-07 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
US5707829A (en) * 1995-08-11 1998-01-13 Genetics Institute, Inc. DNA sequences and secreted proteins encoded thereby
ES2242966T3 (en) * 1995-07-19 2005-11-16 Genetics Institute, Llc CTLA-8HUMANA AND USES OF PROTEINS RELATED TO CTLA-8.
PL336470A1 (en) * 1997-04-25 2000-06-19 Zymogenetics Inc Mammalian cytokin-like factor 7
JP2001510035A (en) * 1997-07-16 2001-07-31 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド Interleukin-20
ATE541930T1 (en) * 1999-12-23 2012-02-15 Genentech Inc IL-17 HOMOLOGUE POLYPEPTIDES AND THEIR THERAPEUTIC USE

Also Published As

Publication number Publication date
JP2003525251A (en) 2003-08-26
CA2401716A1 (en) 2001-09-07
EP1259253A2 (en) 2002-11-27
WO2001064240A3 (en) 2002-02-21
WO2001064240A2 (en) 2001-09-07

Similar Documents

Publication Publication Date Title
AU2003301310A1 (en) Production of biofuels
AU2003234790A1 (en) Process for producing mevalonic acid
AU2002328724A1 (en) Methanol production process
AU2002237729A1 (en) Process for the production of polycarbonate
AU2002307432A1 (en) Production of alpha-lipoic acid
AU2002352353A1 (en) Process for production of styrene
AU5473599A (en) Methods for promoting survival of myelin producing cells
AU2001282174A1 (en) Method for the production of xylitol
AU2001277545A1 (en) Process for the production of 2-hydroxy-4-methylmercaptobutyric acid
AU2002310863A1 (en) Enzymatic process for preparing cephalosporanic acid derivatives using alpha-ketoacid derivatives
AU2002247848A1 (en) Methods for the production of minicircles
AU2001230207A1 (en) Method for the production of 1-amino-3-aryl-uracils
AU2002234051A1 (en) Process for the production of polycarbonate
AU2001241816A1 (en) Methods for promoting production of myelin by schwann cells
AU2003299300A1 (en) METHOD FOR THE PRODUCTION OF R-Alpha-LIPOIC ACID BY FERMENTATION
AU2003201882A1 (en) Processes for producing cmp-n-acetylneuraminic acid
AU2002367896A1 (en) Process for the preparation of ceftiofur acid
AU2001293541A1 (en) Process for production of_polyhydroxyalkanoate
AU2003288532A1 (en) Process for manufacturing fibrin membranes
AU2003261766A1 (en) Process for production of 4-alkylphenols
AU2002229706A1 (en) Process for the fermentative production of d-pantothenic acid
AU2002237704A1 (en) Methods for the stereoselective synthesis of substituted piperidines
AU2001269501A1 (en) Process for producing 2-hydroxy-4-methylthiobutanoic acid
AU2001268019A1 (en) Method for hydrogen production
AUPR095200A0 (en) Cell production